Takeda Teams Up with Code in $2B Rare Disease Pact : vimarsa

The companies will design and develop targeted gene therapies for a liver-directed rare disease program and conduct additional studies for central nervous system-directed rare disease programs. 

Related Keywords

Tomohiro Ohsumi Getty , Madhu Natarajan , , Code Bio , Rare Diseases Drug Discovery Unit , Duchenne Muscular Dystrophy , Resume , Careers , Akeda Teams Up With Code In 2b Rare Disease Pact , Iospace , Advice ,